Cargando…
miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers
NSCLC (non-small cell lung cancer) often exhibits resistance to paclitaxel treatment. Identifying the elements regulating paclitaxel response will advance efforts to overcome such resistance in NSCLC therapy. Using in vitro approaches, we demonstrated that over-expression of the microRNA miR-337-3p...
Autores principales: | Du, Liqin, Subauste, Maria C., DeSevo, Christopher, Zhao, Zhenze, Baker, Michael, Borkowski, Robert, Schageman, Jeoffrey J., Greer, Rachel, Yang, Chin-Rang, Suraokar, Milind, Wistuba, Ignacio I., Gazdar, Adi F., Minna, John D., Pertsemlidis, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377607/ https://www.ncbi.nlm.nih.gov/pubmed/22723956 http://dx.doi.org/10.1371/journal.pone.0039167 |
Ejemplares similares
-
MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs
por: Du, Liqin, et al.
Publicado: (2010) -
LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer
por: Du, Liqin, et al.
Publicado: (2018) -
miR-93-directed down-regulation of DAB2 defines a novel oncogenic pathway in lung cancer
por: Du, Liqin, et al.
Publicado: (2013) -
ELXR: a resource for rapid exon-directed sequence analysis
por: Schageman, Jeoffrey J, et al.
Publicado: (2004) -
miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer
por: Yu, Xiaojie, et al.
Publicado: (2018)